跳至主要内容
临床试验/CTRI/2016/03/006759
CTRI/2016/03/006759已完成1/2 期

Pharmaceutical standardization of Karpanapatru Taila Roll-on prepared with Tila Taila and Narikela Taila and their comparative efficacy in the management of Shvitra (Vitiligo)

Institute for Post Graduate teaching and Research in Ayurveda1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2016年3月28日最近更新:

试验速览

阶段
1/2 期
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Test drug will be effective in reducing patches of vitiligo

研究概览

简要总结

Vitiligo (leukoderma) is a pigmentation disorder with complex causes. Depigmented patches appear on the skin, hair, mucous membranes and the retina. Ayurvedic medicine has been widely used in Indian subcontinent since ages. In the treatment of Shvitra (vitiligo), single drugs like Bakuchi (Psoralea corylifolia Linn.), Khadira (Acacia catechu Wild.), Kakodumbara (Ficus hispida Linn.), Apamarga (Achyranthes aspera Linn.)etc., and compound formulations like Shashilekha Vati, Shvitrari Rasa, Shvitrahara Varti, Gomutrasavaetc., are successfully used. Karpanpatru Taila is one among such compoundformulation mentioned in Siddha Pharmacopoeia and has been safely used to treat Shvitra since many years. In previous study, Karpanpatru Taila was prepared by using three different media keeping same base as Sarshapa Taila. No clinical work was carried out to evaluate role of different Taila as base by using roll-on. Considering this, this study is undertaken to evaluate role of different Taila and their clinical efficacy of Karpanpatru Taila roll-on prepared by Tila Taila and Narikela Taila in Shvitra.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
16.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients having signs and symptoms of Shvitra (vitiligo).
  • Patients having Sadhya Lakshana of Shvitra.
  • Patients having ages of 16 to 60 years.
  • Patients with chronicity of less than 10 years.
  • Wood’s lamp test positive.

排除标准

  • Age < 16 and > 60 years Chronicity more than 10 years.
  • Serious cardiac, renal, hepatic diseases, major illness like IDDM, NIDDM, patches due to burning, chemical, any other serious systemic illness.
  • Gravid and lactating women.
  • Ekanga (Segmental Vitiligo) Patches with Raktaroma (reddish hair) & Samsakta (coalescent).
  • Hypersensitive and Photosensitive patients.

结局指标

主要结局

Test drug will be effective in reducing patches of vitiligo

时间窗: 8 weeks

次要结局

  • It will improve quality of life and complexion of body(8 weeks)

研究者

发起方
Institute for Post Graduate teaching and Research in Ayurveda
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验